Evidence map›Paper›PMID 40176636›Full record

Trial reportJournal of gastroenterology and hepatology2025

The Visibility and Performance of Small Bowel Video Capsule Endoscopy With and Without Pre-Procedural Purge Preparation in the Same Patients.

Reuma Margalit Yehuda, Yana Davidov, Limor Selinger, Bella Ungar, Adi Lahat, Doron Yablecovitch, Sandra Neuman, Uri Kopylov, Shomron Ben Horin, Rami Eliakim and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03555058 (Comprehensive individUalized pRoactive ThErapy of Crohn's Disease Trial), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03555058 nacompletednot on this map

Comprehensive individUalized pRoactive ThErapy of Crohn's Disease Trial: The CURE-CD Trial

TypeinterventionalSponsorSheba Medical CenterRan2018 to 2023Enrolled60ConditionsCD - Crohn's DiseaseArmsTreatment escalation
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Reuma Margalit YehudaDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.ORCID https://orcid.org/0000-0003-3910-7924
Yana DavidovSackler Medical School, Tel Aviv University, Ramat Aviv, Israel.ORCID https://orcid.org/0000-0002-6524-1644
Limor SelingerDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Bella UngarDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Adi LahatDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Doron YablecovitchDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Sandra NeumanDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Uri KopylovDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Shomron Ben HorinDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Rami EliakimDepartment of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Israeli IBD Research Nucleus (IIRN)

Funding

Leona M. and Harry B. Helmsley Charitable Trust
6 · The paper itself

Abstract

backgroundSmall bowel (SB) video capsule endoscopy (VCE) is an established diagnostic tool for the investigation of SB pathologies. Despite clinical studies and a few meta-analyses, an area of continuing controversy is the role of pre-procedural bowel preparation.

objectivesWe compared the visibility and performance of VCE with and without purge preparation in the same patients.

designPost hoc analysis of randomized control trial.

methodsThis is a post hoc analysis of the prospective randomized CURE-CD Trial (Comprehensive individUalized pRoactive ThErapy of Crohn's Disease trial). Established Crohn's disease (CD) patients in clinical remission were enrolled and classified into two groups according to relapse risk assessment. All patients are followed up in our clinic and undergo laboratory tests every 3 months and serial VCE studies every 6 months. The first VCE is done after bowel preparation with a clear liquid diet, PEG, and laxative, whereas the subsequent VCEs, when disease is confined to SB only, are done after a day on clear liquid diet. The VCE visibility is rated (1-4 points) by a blind observer, unaware to the preparation regimen.

resultsForty patients who underwent at least two VCEs, at baseline and after 6 months were included. Visibility scores were similar in these two time points (3.15 vs. 3.10, p = 0.8). Among the low-risk patients' group (n = 16) in whom the clinical parameters (CDAI, CRP, and fecal calprotectin) have not changed significantly during this period, Inflammatory scores assessed by the capsule Lewis score (LS) and PillCam-CD score (PCDS) were similar (median LS 225 vs. 225, p = 0.87, median PCDS 4 vs. 2, p = 0.37).

conclusionThe visibility and performance of SB VCE for monitoring Crohn's disease is not significantly influenced by purge preparation.

trial registrationClinicatrials.gov identifier: NCT03555058.

Indexed as

Capsule EndoscopyCatharticsCrohn DiseaseIntestine, SmallAdultFemaleHumansLeukocyte L1 Antigen ComplexMaleMiddle AgedProspective StudiesRecurrenceYoung AdultCatharticsLeukocyte L1 Antigen Complexbowel preparationCrohn's diseasevideo capsule endoscopyvisibility

Identifiers

PMID40176636
PMCPMC12136803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.